Journal
ALZHEIMERS & DEMENTIA
Volume 12, Issue 5, Pages 577-589Publisher
WILEY
DOI: 10.1016/j.jalz.2015.10.009
Keywords
Biomarkers; Cerebrospinal fluid; Neurodegenerative dementias; Prionopathy; Tauopathy; Synucleinopathy
Categories
Funding
- European Commission: Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY) [222887, FP7-KBBE-2007-2A]
- Neurodegenerative Disease Research (JPND - DEMTEST: Biomarker-based diagnosis of rapidly progressive dementias-optimization of diagnostic protocols) [01ED1201A]
- Alzheimer-Forschung-Initiative e.V. [AFI 12851]
Ask authors/readers for more resources
Introduction: The analysis of cerebrospinal fluid biomarkers gains importance in clinical routine and is effective in substantiating dementia diagnosis in the differential diagnostic context. Methods: We evaluated the levels of beta-amyloid (A beta) 42, A beta 40, tau, and P-tau in a large patient population subdivided into prion diseases, tauopathies, synucleinopathies, and controls. Diagnostic test evaluation was assessed by ROC area under the curve analysis. Results: High tau levels were detected in sporadic Creutzfeldt-Jakob disease (sCJD) and high P-tau levels in Alzheimer's disease (AD) and sCJD. A beta 40 was lower exclusively in prionopathies, but low A beta 42 was detected in AD, sCJD, and Lewy body dementia. When disease groups were stratified according to the underlying proteinopathy, we detected disease-type specificities for all biomarkers. P-tau/tau, A beta 42/40, A beta 42/tau, and A beta 40/tau ratios proved valuable in discriminating disease groups and controls, especially P-tau/tau ratio in the identification of sCJD cases. Discussion: Combining the biomarker panel allows differentiating between various types of neuro-degenerative dementias and contributes to a better understanding of their pathophysiological processes. (C) 2015 Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available